Literature DB >> 18778586

Practical strategies to normalize hyperglycemia without undue hypoglycemia in type 2 diabetes mellitus.

Christopher T Kodl1, Elizabeth R Seaquist.   

Abstract

Hypoglycemia is a common problem in pharmacologically treated patients with type 2 diabetes mellitus and can be a major barrier to achieving optimal glycemic control. For practitioners to minimize and treat hypoglycemia, it is important to understand the physiology, risk factors, and medications associated with hypoglycemia. Through education, lifestyle modifications, medication adjustments, and possibly re-examining glycemic goals, practitioners can reduce the incidence of hypoglycemia while still decreasing the risk of microvascular complications associated with hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18778586     DOI: 10.1007/s11892-008-0065-3

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  69 in total

1.  Hypoglycaemia induced by disopyramide in a patient with Type 2 diabetes mellitus.

Authors:  R M Reynolds; J D Walker
Journal:  Diabet Med       Date:  2001-12       Impact factor: 4.359

2.  Evaluation of the superiority of insulin glargine as basal insulin replacement by continuous glucose monitoring system.

Authors:  Xian Ling Wang; Ju Ming Lu; Chang Yu Pan; Yi Ming Mu; Jing Tao Dou; Jian Ming Ba; Xuemin Wang
Journal:  Diabetes Res Clin Pract       Date:  2006-09-15       Impact factor: 5.602

3.  Severe iatrogenic hypoglycemia in type 2 diabetes mellitus.

Authors:  Philip E Cryer
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-01

4.  Standards of medical care in diabetes--2007.

Authors: 
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

5.  The metabolic clearance of insulin and the feedback inhibition of insulin secretion are altered with aging.

Authors:  R I Fink; R R Revers; O G Kolterman; J M Olefsky
Journal:  Diabetes       Date:  1985-03       Impact factor: 9.461

6.  Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

Authors:  Philip Raskin; Elsie Allen; Priscilla Hollander; Andrew Lewin; Robert A Gabbay; Peter Hu; Bruce Bode; Alan Garber
Journal:  Diabetes Care       Date:  2005-02       Impact factor: 19.112

7.  Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus.

Authors:  L Landstedt-Hallin; A Englund; U Adamson; P E Lins
Journal:  J Intern Med       Date:  1999-09       Impact factor: 8.989

Review 8.  Review of prandial glucose regulation with repaglinide: a solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes?

Authors:  M Nattrass; T Lauritzen
Journal:  Int J Obes Relat Metab Disord       Date:  2000-09

9.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Authors:  Y Ohkubo; H Kishikawa; E Araki; T Miyata; S Isami; S Motoyoshi; Y Kojima; N Furuyoshi; M Shichiri
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

10.  Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study.

Authors:  Francesca Porcellati; Paolo Rossetti; Natalia Ricci Busciantella; Stefania Marzotti; Paola Lucidi; Steven Luzio; David R Owens; Geremia B Bolli; Carmine G Fanelli
Journal:  Diabetes Care       Date:  2007-07-10       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.